EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 270 filers reported holding EXELIXIS INC in Q3 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $312,967 | +44.8% | 16,124 | +19.7% | 0.01% | +25.0% |
Q4 2022 | $216,107 | -87.8% | 13,473 | -88.4% | 0.01% | -86.2% |
Q3 2022 | $1,768,000 | +435.8% | 116,447 | +738.4% | 0.06% | +241.2% |
Q2 2020 | $330,000 | -10.8% | 13,890 | -10.8% | 0.02% | -15.0% |
Q1 2019 | $370,000 | -19.7% | 15,565 | -33.6% | 0.02% | -23.1% |
Q4 2018 | $461,000 | +4.3% | 23,439 | -6.1% | 0.03% | +52.9% |
Q3 2018 | $442,000 | -19.3% | 24,957 | -2.0% | 0.02% | -22.7% |
Q2 2018 | $548,000 | +38.4% | 25,463 | +31.0% | 0.02% | +37.5% |
Q1 2018 | $396,000 | -44.1% | 19,433 | -16.5% | 0.02% | -50.0% |
Q4 2017 | $708,000 | -9.6% | 23,284 | -27.9% | 0.03% | -23.8% |
Q3 2017 | $783,000 | – | 32,316 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |